Vik Chopra
Stock Analyst at Wells Fargo
(n/a)
# 4,475
Out of 4,479 analysts
16
Total ratings
n/a
Success rate
-21.25%
Average return
Main Sectors:
6 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IART Integra LifeSciences Holdings | Downgrades: Equal-Weight | $45 → $25 | $29.19 | -14.35% | 1 | May 7, 2024 | |
| CNMD CONMED | Maintains: Equal-Weight | $98 → $77 | $67.04 | +14.86% | 1 | Apr 25, 2024 | |
| SOLV Solventum | Initiates: Equal-Weight | $69 | $51.60 | +33.72% | 1 | Apr 8, 2024 | |
| MASI Masimo | Upgrades: Overweight | $117 → $160 | $113.42 | +41.07% | 5 | Mar 25, 2024 | |
| ENOV Enovis | Maintains: Overweight | $73 → $79 | $44.71 | +76.69% | 3 | Feb 23, 2024 | |
| GMED Globus Medical | Maintains: Equal-Weight | $63 → $58 | $68.05 | -14.77% | 5 | Sep 15, 2023 |
Integra LifeSciences Holdings
May 7, 2024
Downgrades: Equal-Weight
Price Target: $45 → $25
Current: $29.19
Upside: -14.35%
CONMED
Apr 25, 2024
Maintains: Equal-Weight
Price Target: $98 → $77
Current: $67.04
Upside: +14.86%
Solventum
Apr 8, 2024
Initiates: Equal-Weight
Price Target: $69
Current: $51.60
Upside: +33.72%
Masimo
Mar 25, 2024
Upgrades: Overweight
Price Target: $117 → $160
Current: $113.42
Upside: +41.07%
Enovis
Feb 23, 2024
Maintains: Overweight
Price Target: $73 → $79
Current: $44.71
Upside: +76.69%
Globus Medical
Sep 15, 2023
Maintains: Equal-Weight
Price Target: $63 → $58
Current: $68.05
Upside: -14.77%